AGL

agilon health inc. Common Stock (AGL)

Stock · NYSE · Health Care

$84.93as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Agilon Health Stock Moves Amid Peer Comparison. Recent market activity for Agilon Health has drawn attention to how its performance compares with other medical sector stocks this year. The company's stock is currently trading near a significant support level, which may be influencing investor sentiment. Analysts maintain a wide range of price targets, reflecting varying views on the company's future trajectory.

Active signals

Resistance level
$93.64
Industry
Misc Health and Biotechnology Services

What AGL's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike37-8.6%35%
Bollinger Band Breakdown19-3.5%47%
Bollinger Band Breakout18-3.1%39%
200-Day Moving Average TouchActive now6+7.5%83%
Any 20-session window (baseline)-3.5%44%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About AGL

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in…

Sector
Health Care
Industry
Misc Health and Biotechnology Services
Employees
856

Fundamentals

1-day range
$84.7$88.75
Market cap
$1.45B
P/E (trailing)
—
P/E (forward)
36.05
EPS (trailing)
$-14.06
Dividend yield
—
Beta
3.12
Avg. volume
276.1K
52-week range
$7.48$133.04
Next earnings: November 4, 2026 · EPS estimate $-0.80confirmed

How agilon health inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$5.93BOther$5.69B (96%)SG&A$238.54M (4%)Tax$1.25M (0%)AGL

Source: 10-K filed Feb 25, 2026 · via SEC EDGAR / Finnhub

Operating Income-$463.24M(-8%)

Forecasts

12 analyst ratings

Buy 35%
Hold 60%
Sell 5%
1-year price forecast
High
$146
+71.9%
Median
$115
+35.4%
Low
$85
+0.1%

agilon health inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • AGL
    agilon health inc. Common Stock
    $85.12
    ▼ 3.76%
    Market cap $1.45BP/E —
    $7.48$133.04
  • PGNY
    Progyny Inc. Common Stock
    $26.86
    ▼ 2.17%
    Market cap $2.37BP/E 25.32
    $16.1$33.07
  • VMD
    Viemed Healthcare Inc. Common Shares
    $9.48
    ▼ 2.77%
    Market cap $362.60MP/E 25.72
    $6.05$12.61
  • PARK
    Park Dental Partners Inc. Common Stock
    $18.95
    ▼ 1.33%
    Market cap $96.71MP/E —
    $9.53$26.79
  • CCEL
    Cryo-Cell International Inc. Common Stock
    $4.42
    ▲ 21.10%
    Market cap $28.78MP/E —
    $2.72$4.9
  • MGRX
    Mangoceuticals Inc. Common Stock
    $0.29
    ▼ 9.66%
    Market cap $10.31MP/E —
    $0.162$2.75
  • NIVF
    NewGenIvf Group Limited Class A Ordinary Shares
    $0.279
    ▲ 11.60%
    Market cap $3.36MP/E 0.18
    $0.1722$24,624

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
332.8K
Disposed
3.6K

Institutional Ownership

March 31, 2026

Total shares held
15.05M
Total value held
$117.98M
Institutional holders
92
Top holders this quarter
  • Unknown4.00M
  • Unknown2.10M
  • Unknown1.55M
  • Unknown1.06M
  • Unknown974.9K
  • Unknown873.2K
  • Unknown742.2K
  • Unknown538.5K
  • Unknown364.5K
  • Unknown296.6K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.